Open house Arzneimittelrabattverträge zum Wirkstoff Raltegravir, ATC J05AJ01

TENDER DESCRIPTION

AOK Rheinland-Pfalz/Saarland - The Health Insurance Fund offers discount agreements with the above-mentioned active ingredient to all interested pharmaceutical companies without selection decision. Contract conclusions take place within the framework of an "Open House Model". The offered contracts are non-exclusive; contracts with all market participants (pharmaceutical companies) are desired by AOK Rheinland-Pfalz/Saarland - The Health Insurance Fund. In the open house model, uniform conditions apply to all participants. Contract contents, terms and access procedures are uniform - individual negotiations are not conducted. Contract durations are a maximum of 24 months, with the earliest contract start date being 01.09.2026. All contracts end at the latest 24 months after the date of the earliest contract start, regardless of the respective contract conclusion date. Joining or contract conclusion can take place within the 24-month period on the first day of each month. There is a right of termination with 6 weeks’ notice to the end of the month in accordance with the provisions of the contract. Further information on termination options is included in the contract documents. AOK…

TENDER BRIEF

TENDER DOCUMENTS